EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs

Dawid Skoczek, Jerzy Hohendorff, Maciej T Malecki, Alicia Roig-Merino, Rasmus O Bak, Neli Kachamakova-Trojanowska

Human Genetics · 2026-12 · 145 (1)

DOI: 10.1007/s00439-026-02863-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Genetics, online erschienen am 12.08.2026. Verfasst von Dawid Skoczek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa str 7a, 30-387, Krakow, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Genetic Therapy, Hepatocyte Nuclear Factor 1-alpha, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human induced pluripotent stem cells (hiPSCs) represent a powerful platform for disease modeling, especially in monogenic diseases as they preserve the donor’s genetic background while enabling directed differentiation into disease-relevant cell types. This makes them highly suitable for studying disease mechanisms in a patient-specific and physiologically relevant context. Although CRISPR/Cas9 is widely applied for genome editing, precise correction of pathogenic variants in hiPSCs remains challenging due to the lack of standardized CRISPR component selection and experimental design. Here, we describe an optimized CRISPR-based strategy for correcting a heterozygous HNF1A frameshift mutation (c.235_236insG; p.Glu79Glyfs*16) in HNF1A-MODY patient-derived hiPSCs. Using electroporation, we efficiently delivered CRISPR components, including a ribonucleoprotein complex of Cas9 and single-guide RNA, along with a single-stranded oligodeoxynucleotide repair template. Corrected hiPSC lines were validated for pluripotency, absence of exogenous reprogramming factors, and off-target effects. Additionally, we discuss key technical challenges encountered during the editing process and provide practical recommendations that may improve the generation of mutation-corrected hiPSC lines. These guidelines could serve as a useful reference for researchers employing CRISPR-based strategies for generation of reliable disease modelling tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Genetic TherapyHepatocyte Nuclear Factor 1-alphaInduced Pluripotent Stem CellsRecombinational DNA RepairHumansCRISPR-Cas SystemsMaleAdolescentExons

Substanzen

Hepatocyte Nuclear Factor 1-alphaHNF1A protein, human

Autor:innen und Institutionen

  • Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa str 7a, 30-387, Krakow, Poland.
  • Doctoral School of Exact and Natural Sciences, Jagiellonian University, Lojasiewicza str 11, 30-387, Krakow, Poland.
  • Department of Metabolic Diseases, Jagiellonian University Medical College, Jakubowskiego str 2, 30-688, Krakow, Poland.
  • MaxCyte Inc, Rockville, MD, 20850, USA.
  • Department of Biomedicine, Aarhus University, Aarhus, 8000, Denmark.
  • Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa str 7a, 30-387, Krakow, Poland. neli.kachamakova-trojanowska@uj.edu.pl.

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Skoczek, D., Hohendorff, J., Malecki, M. T., Roig-Merino, A., Bak, R. O., & Kachamakova-Trojanowska, N. (2026). CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs. Human Genetics, 145(1). https://doi.org/10.1007/s00439-026-02863-0

Vancouver

Skoczek D, Hohendorff J, Malecki MT, Roig-Merino A, Bak RO, Kachamakova-Trojanowska N. CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs. Human Genetics. 2026;145(1). doi:10.1007/s00439-026-02863-0

BibTeX
@article{Skoczek2026,
  author = {Skoczek, Dawid and Hohendorff, Jerzy and Malecki, Maciej T and Roig-Merino, Alicia and Bak, Rasmus O and Kachamakova-Trojanowska, Neli},
  title = {CRISPR/Cas9-based repair of a heterozygous HNF1A mutation in patient-derived hiPSCs},
  journal = {Human Genetics},
  year = {2026},
  volume = {145},
  number = {1},
  doi = {10.1007/s00439-026-02863-0}
}
Kostenlos starten →